- 05 November
-
Medsintez Plant participated in a key industry event, Product Innovation Fair in Medicine and Healthcare, which took place in Moscow on October 29–30. Viktor Fisenko, First Deputy Minister of Healthcare of Russia, attended the exhibition of domestic innovations in the field of drugs and medical products.
- 25 October
-
The 3d Scientific and Practical Conference The Ural Peaks. Respiratory Infections 2025 was held in Ekaterinburg on October 15–16 as part of the 4th International Forum Days of Virology 2025. The event organized by the Ministry of Health of the Sverdlovsk Region, the Smorodintsev Research Institute of Influenza, and the Ural State Medical University brought together over 1,100 participants in person and online from 36 cities across Russia.
- 24 October
-
In September 2025, the Russian Ministry of Health issued a registration certificate for a new dosage form of the broad-spectrum antiviral drug TRIAZAVIRIN® for the treatment of ARVI in school-age children—100 mg.
- 20 October
-
On October 10, 2025, a representative delegation visited the Medsintez Plant. Among the visitors, there were members of the State Duma of the Russian Federation, representatives of the Government and Legislative Assembly of the Sverdlovsk Region, the head of the Novouralsk Urban District, and leading regional experts in the field of medical science. The main purpose of the visit was to assess the enterprise's success in import-substituting drug production, become familiar with its brand-new products, and discuss development options of the pharmaceutical industry in the region.
- Home
- Cluster members
- Paradigma LLC
Paradigma LLC
Paradigma LLC is a dynamically developing company specializing in the production and treatment of medical devices. The company successfully operates in the market of medical products and offers comprehensive solutions for health care facilities.
Main areas of activity
- Production of KAP (a liquid embolic system) – manufacturing of specialized medical systems
- Production of syringe kits – manufacturing of components for medical equipment
- Sterilization services – professional treatment of medical devices
Paradigma LLC has launched a sterilization center of (low-temperature) gas sterilization, which allows us to manufacture sterile medical products for the end user. The production capacity of the company allows it to sterilize not only its own products, but also to provide sterilization services to third-party customers.
For the convenience of our customers, we offer services for packaging products in corrugated boxes. The customer can place an order for sterilization of one corrugated box, one cubic meter, or fill the entire useful capacity of the gas chamber with their products. The price of the sterilization service is set individually depending on the volume of products, duration and mode of the cycle.
We have equipped our own high-tech production facilities for the manufacture of syringe kits suitable for a wide range of devices for the intravenous administration of radiopaque substances, which allows us to control the product quality at all stages.
- Quality control at all stages of production. Use of modern technologies and equipment. Wide range of products.
- Flexibility in production of individual orders.
- Our syringe kits meet all quality requirements and standards, which is confirmed by the relevant certificates.
- We offer our customers favorable terms of cooperation, individual approach and fast delivery of products.
Own production of KAP
Sterile, non-absorbable, non-adhesive, X-ray contrast polymer implant for embolization of vascular lesions in various clinical situations. It can be used, among other things, for embolization in case of cerebral vascular pathology, including arteriovenous malformations and hypervascular tumors.
KAP is a liquid embolic system made of the following components:
Ethylene-vinyl alcohol copolymer (EVOH)
Dimethyl sulfoxide (DMSO)
Micronized tantalum powder (Ta)
KAP is able to penetrate into the bloodstream to a given depth (depending on the selected viscosity), thereby ensuring total occlusion of target vessels.
40/4 Gurzufskaya St., 620102 Ekaterinburg
Tel.: (343) 286-14-57
E-mail: paradigma2000@mail.ru
www.angio.pro
